FCEL · sample dossier
42/100
OutdatedGenerated Sep 5, 2026 · 10:00 AM UTC · 62 days ago
This copy is frozen (Sep 5). Sign in to run the same work — filings, valuation, bull and bear, sources — on any US stock or ETF, in about 90 seconds.
Run a fresh dossierFuelCell Energy Inc NEW (DE) · XNAS
Recommendation
Balanced between solid Momentum (83/100) and constrained Growth (10/100).
A mixed picture — no strong reason to buy or sell right now.
AlphaDog Fair Value
Executive Investment Thesis
FuelCell Energy Inc NEW (DE) is an alternative energy manufacturer trading at a market capitalization of $1.20B with a price-to-book ratio of 1.32 and free cash flow per share of -$0.15. A neutral stance is warranted as top-line revenue contracted 4.9% YoY alongside negative valuation multiples including a P/E ratio of -5.42 and EV/EBITDA of -8.12, counterbalanced by a low debt-to-equity ratio of 0.16. The primary risk facing investors is severe equity dilution, evidenced by a +149.4% YoY surge in shares outstanding, alongside a net margin deficit of 113.6%.
Key Metrics to Watch
No material changes found in the last 30 days.
Score 42 · Hold
Apr 30, 2026
Momentum 83/100 — 1Y return 281%.
Levels unavailable — AlphaDog quantitative valuation model did not produce an estimate from comps or DCF
Re-evaluate if
Trim / reconsider if
Think of these dollars as a map of our value estimate for Hold — helpful context, not a reason to override the view.
A Calmer Look · Devil's Advocate
The consensus recommendation to maintain a Hold rating rests on a deceptive solvency profile that masks rapid capital destruction.
May be overlooked
The Altman Z-score of 4.88 is artificially inflated by the market capitalization value of equity ($1.20B) rather than operational health, concealing deeply negative retained earnings and an ROA of -7.9%.
Institutional sponsorship has completely evaporated, with BlackRock holding 0.05%, Vanguard 0.03%, and Legal & General 0.03%, demonstrating that institutional capital refuses to underwrite the business despite a $1.20B valuation.
The sequential revenue decline from $55.02 million to $35.59 million alongside negative gross margins of -32.4% indicates that the business model cannot achieve operating leverage without structurally re-pricing its technology.
Expectations look stretched
Treating a debt-to-equity ratio of 0.16 as balance sheet strength ignores that leverage is kept artificially low solely through aggressive equity dilution (+149.4% YoY shares outstanding).
Overweighting trailing 3-month net insider purchases of $423,192 as an operational vote of confidence when it represents less than 0.04% of the $1.20B market cap.
Relying on trailing 1-year momentum of 281.4% while dismissing the immediate technical deterioration of a -26.4% 1-month decline below the 50-day moving average.
Revenue growth YoY deteriorates below the current -4.9% print.
Revenue growth YoY deteriorates below the current -4.9% print.
Snapshot returns at report publication
1 month
-26.4%
3 months
-13.7%
6 months
+96.7%
1 year
+281.4%
At a Glance
A smaller company has mixed momentum at unprofitable earnings.
Top Holders
Financial Performance
Go deeper
For learning and research only — not investment advice. AlphaDog doesn’t hold stocks and isn’t your financial advisor.
You just read a full FCEL dossier — scored verdict, valuation, and both sides, with sources. Sign in to run that on a name you hold, on current filings. A free account includes 10 credits a week, 1 per fresh run.